Theravance, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Theravance, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Theravance, Inc.. The Group's principal activity is that of a biopharmaceutical company with a pipeline of internally discovered product candidates. It focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. Its programs include: telavancin for the treatment of serious Gram-positive bacterial infections with Astellas Pharma Inc. and Horizon program and the Bifunctional Muscarinic Antagonist-beta2 Agonist program with GlaxoSmithKline PLC.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report